186 related articles for article (PubMed ID: 15774470)
1. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
J Biol Chem; 2005 May; 280(20):19516-26. PubMed ID: 15774470
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
Button L; Mireylees SE; Germack R; Dickenson JM
Exp Physiol; 2005 Sep; 90(5):747-54. PubMed ID: 15964902
[TBL] [Abstract][Full Text] [Related]
3. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells.
Lee JY; Jhun BS; Oh YT; Lee JH; Choe W; Baik HH; Ha J; Yoon KS; Kim SS; Kang I
Neurosci Lett; 2006 Mar; 396(1):1-6. PubMed ID: 16324785
[TBL] [Abstract][Full Text] [Related]
4. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
Mlejnek P; Dolezel P; Frydrych I
J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
[TBL] [Abstract][Full Text] [Related]
5. Cell-signaling evidence for adenosine stimulation of coronary smooth muscle proliferation via the A1 adenosine receptor.
Shen J; Halenda SP; Sturek M; Wilden PA
Circ Res; 2005 Sep; 97(6):574-82. PubMed ID: 16100051
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.
Germack R; Griffin M; Dickenson JM
J Mol Cell Cardiol; 2004 Nov; 37(5):989-99. PubMed ID: 15522276
[TBL] [Abstract][Full Text] [Related]
7. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes.
Germack R; Dickenson JM
J Mol Cell Cardiol; 2005 Sep; 39(3):429-42. PubMed ID: 16005018
[TBL] [Abstract][Full Text] [Related]
8. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
9. The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38.
Schulte G; Fredholm BB
Exp Cell Res; 2003 Oct; 290(1):168-76. PubMed ID: 14516797
[TBL] [Abstract][Full Text] [Related]
10. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
Kim GD; Oh J; Jeong LS; Lee SK
Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
[TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
13. Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
Madi L; Rosenberg-Haggen B; Nyska A; Korenstein R
Exp Dermatol; 2013 Jan; 22(1):74-7. PubMed ID: 23088669
[TBL] [Abstract][Full Text] [Related]
14. Mesangial cell apoptosis induced by stimulation of the adenosine A3 receptor: signaling and apoptotic events.
Duann P; Ho TY; Desai BD; Kapoian T; Cowen DS; Lianos EA
J Investig Med; 2005 Jan; 53(1):37-43. PubMed ID: 16025880
[TBL] [Abstract][Full Text] [Related]
15. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
Kim TH; Kim YK; Woo JS
Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3'-kinase.
Hammarberg C; Fredholm BB; Schulte G
Biochem Pharmacol; 2004 Jan; 67(1):129-34. PubMed ID: 14667935
[TBL] [Abstract][Full Text] [Related]
17. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
[TBL] [Abstract][Full Text] [Related]
18. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.
Campbell M; Allen WE; Sawyer C; Vanhaesebroeck B; Trimble ER
Circ Res; 2004 Aug; 95(4):380-8. PubMed ID: 15242975
[TBL] [Abstract][Full Text] [Related]
19. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis.
Gao Z; Li BS; Day YJ; Linden J
Mol Pharmacol; 2001 Jan; 59(1):76-82. PubMed ID: 11125027
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells.
Graham S; Combes P; Crumiere M; Klotz KN; Dickenson JM
Eur J Pharmacol; 2001 May; 420(1):19-26. PubMed ID: 11412835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
